Cargando...
Immune Checkpoint Inhibitor-Associated Colitis and Hepatitis
Immune checkpoint inhibitors (ICPIs) are monoclonal antibodies that target downregulators of the anti-cancer immune response: cytotoxic T-lymphocyte antigen-4, programmed cell death protein-1, and its ligand PD-L1. ICPIs are now approved for the treatment of a wide array of malignancies, with rates...
Guardado en:
| Publicado en: | Clin Transl Gastroenterol |
|---|---|
| Autores principales: | , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Nature Publishing Group US
2018
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6143593/ https://ncbi.nlm.nih.gov/pubmed/30228268 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41424-018-0049-9 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|